还没做过化疗，EGFR是野生型的病友一定要去做ALK的检测

jzjqian 发表于 2012-7-25 15:45

7 ^4 L, g6 ^) c- j) r& G2 R                               
登录/注册后可看大图

" _! n+ W" e2 u) |3 W请教，像我这样的，手术22个月了，还能去原手术医院拿到病理作EGFR检查么？

! N& y, y6 K2 m2 u4 @3 v8 P可以，但要有针对性，

请问，肺鳞癌，只做过一次化疗，骨髓抑制严重，后吃特罗凯4个月基本无效，可以参加实验组吗？

不可以了,要没做过任何治疗的,包括化疗和靶向药

Concomitant EGFR mutation and EML4-ALK gene fusion in non-small cell lung cancer.  Print this page  


# x0 X  ^+ t. A5 c; A4 X* R% hSub-category:
0 _. c2 N- u, n; D8 t* SMolecular Targets
! H; R* r3 N, N  L, I
# d( @% ^8 f, `3 w$ V; C, f
0 Q6 s2 Q6 h$ {: t9 A/ UCategory:
2 L, ?& x* X. M  y$ t+ {6 YTumor Biology
3 G! ]4 o# f2 ~7 r) o0 M
  H( [( K0 ~$ r1 ?- f) k9 F" ~
: g/ A1 _' m$ d& A+ E: h  {Meeting:
2011 ASCO Annual Meeting

2 X7 Y7 _% T0 u3 l5 p9 ?- [- q
Session Type and Session Title:
Poster Discussion Session, Tumor Biology


Abstract No:
10517
3 r' l/ z, w" `2 n: w9 V: v
, J7 v' a7 G. H  I9 F( \& K0 T6 ^
0 V  Z2 K: U4 f- I( VCitation:
J Clin Oncol 29: 2011 (suppl; abstr 10517)

3 x9 ^8 b5 i5 `& c# G& ]8 r
7 N0 @! k8 K" }4 v- KAuthor(s):
$ f8 H" g; J+ c+ z) gJ. Yang, X. Zhang, J. Su, H. Chen, H. Tian, Y. Huang, C. Xu, Y. L. Wu; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China; Guangdong Lung Cancer Institute, Medical Research Center of Guangdong General Hospital, Guangzhou, China; Guangdong Lung Cancer Institute, Guangzhou, China; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China
/ p9 k. C& j3 R& ]+ j0 v

8 U5 D- u/ O& A4 B& }
Abstracts that were granted an exception in accordance with ASCO's Conflict of Interest Policy are designated with a caret symbol (^) here and in the printed Proceedings.

2 S$ C8 C/ R* _" s# z6 o4 o5 q* I( PAbstract Disclosures

4 M+ l5 z7 I# o) f9 @: uAbstract:


0 U6 G! ?/ b/ E2 w2 bBackground: The fusion of the anaplastic lymphoma kinase (ALK) with the echinoderm microtubule-associated protein-like 4 (EML4) and epidermal growth factor receptor (EGFR) mutations are considered mutually exclusive. Advanced non-small cell lung cancer (NSCLC) patients with EML4-ALK did not benefit from EGFR tyrosine kinase inhibitors (TKIs). Methods: Multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) followed by sequencing was performed for EML4-ALK fusion status detection. EGFR and KRAS mutations were determined by direct DNA sequencing. Positive results of EML4-ALK fusion were also confirmed by RACE-coupled PCR sequencing. Results: From April 2010 to January 2011, 412 patients (398 with NSCLC; 14 with SCLC) were tested for mutation status of EGFR, KRAS and EML4-ALK respectively. Frequency of EML4-ALK fusion was 10.6% (42/398) in NSCLC patients. No patients with SCLC were found to have positive EML4-ALK fusion. Frequency of concomitant EGFR and EML4-ALK gene mutations was 1.0% (4/398) in NSCLC patients, and their variants of EML4-ALK gene mutations were Variant 1 (3 patients) and Variant 6 (1 patient); being never smokers, all of them were diagnosed with advanced (3 with stage †W and 1 with stage IIIB) adenocarcinoma harbouring wild type KRAS. Two female stage †W patients with double gene mutations (1 with L858R and Variant 1; 1 with exon19 deletion and Variant 6) received first-line gefitinib which is one kind of EGFR TKIs and achieved partial response. Conclusions: Though being rare events, NSCLC patients harbouring concomitant EGFR mutation and EML4-ALK gene fusion are sensitive to first-line EGFR TKIs. Whether they could also benefit from ALK inhibition after failure to EGFR TKIs warranted further investigation.

由吴一龙教授牵头的A80810029临床试验上周启动，初诊未治疗的晚期肺腺癌患者检测到ALK阳性，可参加一线crizotinib 对比力比泰+卡铂的临床研究，药物全部免费，即使分配到力比泰组，疾病进展之后可免费获得crizotinib.

没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

boeun 发表于 2012-11-18 16:37

                               
登录/注册后可看大图

8 L( \; W$ M* N$ q8 Z没有手术，只化疗过，现吃靶向药，未突变，alk未测，有机会入组吗？

4 o% H% c4 a1 J+ v化疗过的没机会了

平安！ 发表于 2012-7-20 11:20

4 c* ~# k5 x4 [                               
登录/注册后可看大图

易瑞沙、特罗凯有效的病人基本上可以断定ALK（-）。极其罕见EGFR、ALK同时突变的。
0 U" a( |% a" c+ {: e- UALK一个指标医院要900多 ...

8 g% N7 O+ J0 D" l  j平安，真的没有希望吗？我弟弟虽然特罗凯有效，但是ＥＧＦＲ是野生型，不是突变啊。有没有必要去检测ＡＬＫ呢？
+ ~0 u5 t4 e/ \
5 k9 c1 a2 _/ D& R现在病情进展，快没招儿了。

好像想加入挺困难的

小地方没条件做啊